APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,154 | -14.9% | 55,000 | +10.0% | 0.01% | -28.6% |
| Q4 2022 | $2,532 | -99.9% | 50,000 | 0.0% | 0.01% | -22.2% |
| Q3 2022 | $3,179,000 | +24.7% | 50,000 | -13.3% | 0.01% | +28.6% |
| Q2 2022 | $2,549,000 | +93.0% | 57,700 | +116.1% | 0.01% | +133.3% |
| Q1 2022 | $1,321,000 | -35.2% | 26,700 | -38.5% | 0.00% | -40.0% |
| Q4 2021 | $2,038,000 | +147.3% | 43,400 | +75.7% | 0.01% | +150.0% |
| Q3 2021 | $824,000 | -66.1% | 24,700 | -36.2% | 0.00% | -71.4% |
| Q2 2021 | $2,433,000 | +14.7% | 38,700 | -23.7% | 0.01% | 0.0% |
| Q1 2021 | $2,121,000 | -23.4% | 50,700 | 0.0% | 0.01% | -30.0% |
| Q4 2020 | $2,769,000 | +55.6% | 50,700 | -18.5% | 0.01% | +25.0% |
| Q3 2020 | $1,780,000 | -45.7% | 62,200 | -53.6% | 0.01% | -50.0% |
| Q2 2019 | $3,276,000 | – | 134,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |